The strategy will include a biopharma-focused network with three new National Institutes of Pharmaceutical Education and ...

A Rs 10,000-crore push aims to build India’s biopharma and advanced manufacturing capabilities as disease patterns and technology priorities shift.

Finance Minister Nirmala Sitharaman on Sunday proposed a Rs 10,000 crore allocation over the next five years to boost India’s ...

Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...

Finance Minister Nirmala Sitharaman has proposed setting up five medical tourism hubs and launching a ‘Biopharma Shakti ...

Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...

Finance Minister Nirmala Sitharaman, during her ninth consecutive Budget speech, announced an outlay of ₹10,000 crore under ...

Union Finance Minister Nirmala Sitharaman made one of the most significant announcements of Budget 2026 by unveiling ‘Biopharma Shakti', a flagship initiative with an outlay of ₹10,000 crore over the ...

She said, I propose the Biopharma Shakti with an outlay of Rs 10,000 crore over the next five years, this will build the ecosystem for domestic production of biologics and biosimilars. The strategy ...

Budget 2026: Sitharaman allocates Rs 10000 crore to make India biopharma hub ...

Finance Minister proposes 5 medical tourism hubs & Rs 10,000 crore for Biopharma Shakti program to boost healthcare and research.